UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q8I4X0 (ACT1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Actin-1; Actin I; | |
Q8ILW9 (ACT2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Actin-2; Actin II; | |
Q8IDN4 (ALBA2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | DNA/RNA-binding protein ALBA2; | |
A0A5K1K8Y8 (ALBA4_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | DNA/RNA-binding protein ALBA4; | |
Q7KQL3 (ARF1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | ADP-ribosylation factor 1; | |
Q8I384 (ARGI_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Arginase; | |
Q8I1T8 (ASNA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | ATPase ASNA1 homolog; Arsenical pump-driving ATPase homolog; Arsenite-stimulated ATPase; | |
C0H559 (ATAT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Alpha-tubulin N-acetyltransferase; Acetyltransferase mec-17 homolog; | |
O96188 (CERI1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Rhoptry surface protein CERLI1; Cytosolically exposed rhoptry leaflet interacting protein 1; Rhoptry apical surface protein 2; | |
Q8I4R4 (CHIT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Chitinase; | |
Q8I6T1 (P4548_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Gametocyte surface protein P45/48; | |
Q8IIK4 (PDX2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Pyridoxal 5'-phosphate synthase subunit PDX2; Pyridoxal 5'-phosphate synthase glutaminase subunit; | |
C6KSX1 (PF12P_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Surface protein P12p; | |
Q8I1Y5 (PF36_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Sporozoite surface protein P36; | |
Q8I1Y0 (PF41_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Merozoite surface protein P41; Merozoite surface protein P41, processed form; | |
Q8IDN0 (PFS47_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Female gametocyte surface protein P47; | |
Q7KQM4 (PLM1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Plasmepsin I; Aspartic hemoglobinase I; Plasmepsin 1; | |
Q8I6V3 (PLM2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Plasmepsin II; Plasmepsin 2; | |
Q8IM15 (PLM3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Plasmepsin III; Histo-aspartic protease; PfHAP; Plasmepsin 3; | |
Q8IM16 (PLM4_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Plasmepsin IV; Plasmepsin 4; | |
Q7KQM1 (PRI1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | DNA primase small subunit; DNA primase 53 kDa subunit; | |
Q8IDF6 (PURA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Adenylosuccinate synthetase; IMP--aspartate ligase; | |
Q76NM7 (RAB5B_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Ras-related protein Rab-5B; | |
Q6LFD5 (RK18_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Large ribosomal subunit protein uL18c; 50S ribosomal protein L18, apicoplastic; | |
Q8IBZ9 (CRT_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Chloroquine resistance transporter; PfCRT; Probable transporter cg10; | |
Q7K740 (CSP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Circumsporozoite protein; Circumsporozoite protein C-terminus; | |
C0H4E4 (DCXH_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Doublecortin domain-containing protein; PfApicortin; | |
O97235 (EFTS_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Elongation factor Ts, mitochondrial; | |
Q25820 (EFTU_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Elongation factor Tu, apicoplast; | |
Q8IJN7 (ENO_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Enolase; 2-phospho-D-glycerate hydro-lyase; 2-phosphoglycerate dehydratase; | |
Q8IDM6 (ENT1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Nucleoside transporter 1; | |
Q76NM1 (ERD2_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | ER lumen protein-retaining receptor; | |
C6KT68 (FENR_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Ferredoxin--NADP reductase, apicoplast; | |
Q8IED5 (FER_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Ferredoxin, apicoplast; | |
Q8I5I8 (GAP45_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Glideosome-associated protein 45; | |
Q8I2X3 (GAP50_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Glideosome-associated protein 50; Secreted acid phosphatase; | |
Q8I2D9 (GEX10_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | CX3CL1-binding protein 1; Gametocyte exported protein 10; | |
Q8I566 (GLYA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Serine hydroxymethyltransferase; PfSHMTc; | |
Q8ILQ7 (GST_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Glutathione S-transferase; | |
Q8IL04 (HDP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Heme ligase; Heme detoxification protein; Hemozoin synthase; | |
Q8I333 (ICP_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Falstatin; Cysteine protease inhibitor; | |
O77392 (IPYR_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Probable inorganic pyrophosphatase; Pyrophosphate phospho-hydrolase; | |
A0A144A134 (ISN1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | IMP-specific 5'-nucleotidase 1; | |
P62368 (ISPF_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, apicoplast; PfIspF; | |
Q8IBP3 (ITPA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Inosine triphosphate pyrophosphatase; Non-canonical purine NTP pyrophosphatase; Non-standard purine NTP pyrophosphatase; Nucleoside-triphosphate diphosphatase; Nucleoside-triphosphate pyrophosphatase; | |
Q8IJV6 (KAD1_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Adenylate kinase 1; | |
Q8I1T1 (KAD3_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | GTP:AMP phosphotransferase; | |
Q8I236 (KAD6_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Adenylate kinase isoenzyme 6 homolog; Dual activity adenylate kinase/ATPase; PfAKLP1; | |
Q8I4S1 (KTHY_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Thymidylate kinase; Thymidine monophosphate kinase; Thymidylate/guanylate kinase; | |
Q8IDQ0 (LIPA_PLAF7) | Swiss-Prot | Plasmodium falciparum (isolate 3D7) | Lipoyl synthase, apicoplast; Lipoate synthase; Lipoic acid synthase; |
Plasmodium falciparum is a protozoan parasite that resides in human red blood cells, but can also infect the brain and liver. P. falciparum is one of the species of Plasmodium that causes malaria in humans. It has a complex life-cycle requiring both human and female Anopheles mosquito. P. falciparum is responsible for the disease's most dangerous form, malignant or falciparum malaria, which has the highest complication rates and mortality.
With more than 200 million cases and 400,000 deaths from malaria worldwide, P. falciparum (causing roughly 50% of the cases) has been the focus of malaria research for decades.
The genome of P. falciparum was first sequenced in 2002.
From left to right: i) The number of proteins in the reference proteome of Plasmodium falciparum, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Plasmodium falciparum for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Plasmodium falciparum, please visit UniProtKB.
You can easily download the latest protein sequences for Plasmodium falciparum proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_02 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
5,361 | 3,638 | 6,595 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Plasmodium falciparum reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Plasmodium falciparum proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 10-mer | 12-mer | 14-mer | 16-mer | 24-mer | 26-mer | 40-mer | 60-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,923 | 478 | 39 | 59 | 8 | 45 | 10 | 4 | 4 | 9 | 3 | 4 | 4 | 1 | 3 | 1 |